» Articles » PMID: 29621057

Controlling for Frailty in Pharmacoepidemiologic Studies of Older Adults: Validation of an Existing Medicare Claims-based Algorithm

Overview
Journal Epidemiology
Specialty Public Health
Date 2018 Apr 6
PMID 29621057
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Frailty is a geriatric syndrome characterized by weakness and weight loss and is associated with adverse health outcomes. It is often an unmeasured confounder in pharmacoepidemiologic and comparative effectiveness studies using administrative claims data.

Methods: Among the Atherosclerosis Risk in Communities (ARIC) Study Visit 5 participants (2011-2013; n = 3,146), we conducted a validation study to compare a Medicare claims-based algorithm of dependency in activities of daily living (or dependency) developed as a proxy for frailty with a reference standard measure of phenotypic frailty. We applied the algorithm to the ARIC participants' claims data to generate a predicted probability of dependency. Using the claims-based algorithm, we estimated the C-statistic for predicting phenotypic frailty. We further categorized participants by their predicted probability of dependency (<5%, 5% to <20%, and ≥20%) and estimated associations with difficulties in physical abilities, falls, and mortality.

Results: The claims-based algorithm showed good discrimination of phenotypic frailty (C-statistic = 0.71; 95% confidence interval [CI] = 0.67, 0.74). Participants classified with a high predicted probability of dependency (≥20%) had higher prevalence of falls and difficulty in physical ability, and a greater risk of 1-year all-cause mortality (hazard ratio = 5.7 [95% CI = 2.5, 13]) than participants classified with a low predicted probability (<5%). Sensitivity and specificity varied across predicted probability of dependency thresholds.

Conclusions: The Medicare claims-based algorithm showed good discrimination of phenotypic frailty and high predictive ability with adverse health outcomes. This algorithm can be used in future Medicare claims analyses to reduce confounding by frailty and improve study validity.

Citing Articles

Frailty Trajectories Following Adjuvant Chemotherapy and Mortality in Older Women With Breast Cancer.

Duchesneau E, Kim D, Sturmer T, Her Q, Zhang Z, Pajewski N JAMA Netw Open. 2025; 8(3):e250614.

PMID: 40072432 PMC: 11904708. DOI: 10.1001/jamanetworkopen.2025.0614.


Unleashing frailty from laboratory into real world: A critical step toward frailty-guided clinical care of older adults.

Kim D J Am Geriatr Soc. 2024; 72(11):3299-3314.

PMID: 39166879 PMC: 11560722. DOI: 10.1111/jgs.19151.


Longitudinal Changes in a Claims-Based Frailty Proxy Measure Compared to Concurrent Changes in the Fried Frailty Phenotype.

Duchesneau E, Kim D, Sturmer T, Reeder-Hayes K, Edwards J, Faurot K J Gerontol A Biol Sci Med Sci. 2024; 79(9).

PMID: 38995106 PMC: 11333825. DOI: 10.1093/gerona/glae174.


Assessing the Benefits and Harms of Pharmacotherapy in Older Adults with Frailty: Insights from Pharmacoepidemiologic Studies of Routine Health Care Data.

Kim D, Park C, Ko D, Lin K, Glynn R Drugs Aging. 2024; 41(7):583-600.

PMID: 38954400 PMC: 11884328. DOI: 10.1007/s40266-024-01121-0.


Longitudinal trajectories of a claims-based frailty measure during adjuvant chemotherapy in women with stage I-III breast cancer.

Duchesneau E, Reeder-Hayes K, Sturmer T, Kim D, Edwards J, Lund J Oncologist. 2024; 29(10):e1291-e1301.

PMID: 38716777 PMC: 11449071. DOI: 10.1093/oncolo/oyae092.


References
1.
Kiely D, Cupples L, Lipsitz L . Validation and comparison of two frailty indexes: The MOBILIZE Boston Study. J Am Geriatr Soc. 2009; 57(9):1532-9. PMC: 2792729. DOI: 10.1111/j.1532-5415.2009.02394.x. View

2.
Fried L, Tangen C, Walston J, Newman A, Hirsch C, Gottdiener J . Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56(3):M146-56. DOI: 10.1093/gerona/56.3.m146. View

3.
Segal J, Chang H, Du Y, Walston J, Carlson M, Varadhan R . Development of a Claims-based Frailty Indicator Anchored to a Well-established Frailty Phenotype. Med Care. 2017; 55(7):716-722. PMC: 5471130. DOI: 10.1097/MLR.0000000000000729. View

4.
Glynn R, Schneeweiss S, Wang P, Levin R, Avorn J . Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol. 2006; 59(8):819-28. DOI: 10.1016/j.jclinepi.2005.12.012. View

5.
Jackson M, Yu O, Nelson J, Naleway A, Belongia E, Baxter R . Further evidence for bias in observational studies of influenza vaccine effectiveness: the 2009 influenza A(H1N1) pandemic. Am J Epidemiol. 2013; 178(8):1327-36. PMC: 7314269. DOI: 10.1093/aje/kwt124. View